• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Risk Factors for No Valid Liver Graft. Multivariate Study Based on the Variables Included in the Donation Protocol of the National Trasplant Organisation.

作者信息

Castillo Tuñón Juan Manuel, Marín Gómez Luis Miguel, Suárez Artacho Gonzalo, Cepeda Franco Carmen, Bernal Bellido Carmen, Álamo Martínez José María, Padillo Ruiz Francisco Javier, Gómez Bravo Miguel Ángel

机构信息

Hospital Universitario de Badajoz, Badajoz, España.

Hospital Universitario Virgen del Rocio, Sevilla, España.

出版信息

Cir Esp (Engl Ed). 2020 Dec;98(10):591-597. doi: 10.1016/j.ciresp.2020.03.021. Epub 2020 Jun 2.

DOI:10.1016/j.ciresp.2020.03.021
PMID:32507309
Abstract

INTRODUCTION

Among the strategies designed to optimize the number of existing liver grafts for transplantation, the implementation of the graft assessment process is one of the least explored. The main objective is to identify the risk factors presented by liver donors for «NO validity». Secondly, we analyzed the coincidence between the surgeon's assessment and that of the anatomo-pathologist in the invalid donors.

MATERIAL AND METHOD

Retrospective study conducted from a prospective database that analyzes 190 liver donors, 95 valid and 95 NOT valid. The variables of each of them corresponding to the donation protocol of the National Transplant Organization are studied. Through a multivariate study we determine the independent risk factors of NO validity. We checked the causes of NO validity argued with the histopathological findings of these grafts.

RESULTS

The independent risk factors of non-validity in the multivariate study (P < .05) were: dyslipidemia, personal medical history other than cardiovascular and abdominal surgical risk factors, GGT, BrT, and the result of previous liver ultrasound. The 3 most frequent causes of NO validity were: steatosis, fibrosis and macroscopic appearance of the organ. 78% of the biopsies confirmed the NO validity of the graft (in 57.9% of the cases the histological findings coincided with those described by the surgeon). The 22.1% of the biopsies hadńt pathological findings.

CONCLUSIONS

The determination of the risk factors of NO validity will contribute to the design of future assessment scores that are useful tools in the process of liver graft assessment.).

摘要

相似文献

1
Risk Factors for No Valid Liver Graft. Multivariate Study Based on the Variables Included in the Donation Protocol of the National Trasplant Organisation.
Cir Esp (Engl Ed). 2020 Dec;98(10):591-597. doi: 10.1016/j.ciresp.2020.03.021. Epub 2020 Jun 2.
2
The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment.活检供体肝:将宏观脂肪变性纳入高危供体评估。
Liver Transpl. 2010 Jul;16(7):874-84. doi: 10.1002/lt.22085.
3
Utility of pre-procurement bedside liver biopsy in the deceased extended-criteria liver donor.
Clin Transplant. 2014 Dec;28(12):1358-64. doi: 10.1111/ctr.12461.
4
The histological assessment of liver fibrosis in grafts from extended criteria donors predicts the outcome after liver transplantation: A retrospective study.移植肝中扩展标准供体来源的肝纤维化的组织学评估可预测肝移植后的结局:一项回顾性研究。
Dig Liver Dis. 2020 Feb;52(2):185-189. doi: 10.1016/j.dld.2019.05.013. Epub 2019 May 31.
5
The UK DCD Risk Score: A new proposal to define futility in donation-after-circulatory-death liver transplantation.英国 DCD 风险评分:一种定义脑死亡后捐献肝脏移植中无效性的新提案。
J Hepatol. 2018 Mar;68(3):456-464. doi: 10.1016/j.jhep.2017.10.034. Epub 2017 Nov 15.
6
Expanding the donor pool: Donation after circulatory death and living liver donation do not compromise the results of liver transplantation.扩大供体池:循环死亡后捐献和活体肝移植不会影响肝移植的结果。
Liver Transpl. 2018 Jun;24(6):779-789. doi: 10.1002/lt.25068. Epub 2018 May 14.
7
Hepatic steatosis in organ donors: disparity between surgery and histology?器官捐献者的肝脏脂肪变性:手术与组织学之间的差异?
Transplant Proc. 2009 Jul-Aug;41(6):2557-60. doi: 10.1016/j.transproceed.2009.06.121.
8
Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study.脂肪肝。我们可以在 OLTX 中使用它们吗?一项前瞻性基线肝活检研究的结果数据。
Ann Hepatol. 2012 Nov-Dec;11(6):891-8.
9
Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus.利用心死亡后捐献者的肝脏移植物为丙型肝炎病毒感染者进行移植。
Liver Transpl. 2011 Jun;17(6):641-9. doi: 10.1002/lt.22258.
10
The status of cadaveric organ donation for liver transplantation in Saudi Arabia.沙特阿拉伯尸体器官捐赠用于肝移植的现状。
Saudi Med J. 2002 May;23(5):509-12.

引用本文的文献

1
Development of a liver graft assessment expert machine-learning system: when the artificial intelligence helps liver transplant surgeons.肝移植评估专家机器学习系统的开发:人工智能如何助力肝移植外科医生
Front Surg. 2023 Sep 22;10:1048451. doi: 10.3389/fsurg.2023.1048451. eCollection 2023.